Considering that NF-kB signaling pathways are associated with a large number of inflammatory diseases including arthritis, cancer, and atherosclerosis, hence IKKβ represents a pivotal therapeutic target in the NF-κB pathway4,9,10. This evidence concerns the gene NFKB1 and cancer.